DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Relenza (Zanamivir) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

RELENZA SUMMARY

RELENZA ® (zanamivir) Inhalation Powder, for oral inhalation

The active component of RELENZA is zanamivir, an antiviral agent.

RELENZA is indicated for treatment of uncomplicated acute illness due to influenza A and B virus in adults and pediatric patients 7 years and older who have been symptomatic for no more than 2 days (see Description of Clinical Studies and PRECAUTIONS).

RELENZA is not recommended for treatment of patients with underlying airways disease (such as asthma or chronic obstructive pulmonary disease) (see WARNINGS and PRECAUTIONS).
See all Relenza indications & dosage >>

RELENZA NEWS HIGHLIGHTS

Media Articles Related to Relenza (Zanamivir)

New Warnings for Flu Drug Relenza
Source: MedicineNet oseltamivir Specialty [2008.04.03]

Influenza vaccine effective in young children (Reuters)
Source: Y! Health Cold & Flu News [2008.11.26]

Start Of Phase III Trial On The Anti-influenza Drug CS-8958
Source: Flu / Cold / SARS News From Medical News Today [2008.11.17]

A New Way To Predict Outbreaks: Replikin Peptide Concentration In H5N1 Influenza Virus Genome As A Marker For Lethal Outbreaks
Source: Bird Flu / Avian Flu News From Medical News Today [2008.11.13]

Design Of System That Will Revolutionise Control Of Influenza Epidemics
Source: Flu / Cold / SARS News From Medical News Today [2008.11.13]

more >>

Published Studies Related to Relenza (Zanamivir)

A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. [2008.01]

Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. [2007.08]

Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. [2003.06]

Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza. [2003]

Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. [2002.12.01]

more >>

Clinical Trials Related to Relenza (Zanamivir)

A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects [Terminated]

A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-Term Prophylaxis Against Pandemic Influenza [Not yet recruiting]

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-Term Prophylaxis Against Pandemic Influenza: PIPET B [Not yet recruiting]

more >>

Page last updated: 2008-11-26

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008